The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for leniolisib (Ballia Holdings Pty Ltd)
Active ingredients
leniolisib
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS) in adults and adolescents 12 years of age or older
Therapeutic area
Immunology